Best Practice & Research Clinical Haematology

Papers
(The H4-Index of Best Practice & Research Clinical Haematology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
COVID-19 disease and immune dysregulation36
Immunologic effects on the haematopoietic stem cell in marrow failure25
The promise of macrophage directed checkpoint inhibitors in myeloid malignancies20
CD33 directed bispecific antibodies in acute myeloid leukemia20
Immune checkpoint inhibitors in acute myeloid leukemia19
COVID-19 and antiphospholipid antibodies18
Perspectives on current survival and new developments in AML17
Treatment of telomeropathies17
Mechanisms for resistance in AML insights into molecular pathways mediating resistance to venetoclax16
TCR gene-engineered cell therapy for solid tumors14
Congenital amegakaryocytic thrombocytopenia – Not a single disease14
COVID-19 and HSCT (Hematopoietic stem cell transplant)14
CD123 bi-specific antibodies in development in AML: What do we know so far?13
Distinguishing constitutional from acquired bone marrow failure in the hematology clinic13
0.051791906356812